1. Home
  2. PRTA vs IBEX Comparison

PRTA vs IBEX Comparison

Compare PRTA & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • IBEX
  • Stock Information
  • Founded
  • PRTA 2012
  • IBEX 2017
  • Country
  • PRTA Ireland
  • IBEX United States
  • Employees
  • PRTA N/A
  • IBEX N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • IBEX EDP Services
  • Sector
  • PRTA Health Care
  • IBEX Technology
  • Exchange
  • PRTA Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • PRTA 472.1M
  • IBEX 386.9M
  • IPO Year
  • PRTA N/A
  • IBEX 2020
  • Fundamental
  • Price
  • PRTA $8.20
  • IBEX $29.53
  • Analyst Decision
  • PRTA Buy
  • IBEX Hold
  • Analyst Count
  • PRTA 10
  • IBEX 2
  • Target Price
  • PRTA $14.86
  • IBEX $27.00
  • AVG Volume (30 Days)
  • PRTA 1.2M
  • IBEX 83.2K
  • Earning Date
  • PRTA 08-04-2025
  • IBEX 09-11-2025
  • Dividend Yield
  • PRTA N/A
  • IBEX N/A
  • EPS Growth
  • PRTA N/A
  • IBEX 48.53
  • EPS
  • PRTA N/A
  • IBEX 2.25
  • Revenue
  • PRTA $10,341,000.00
  • IBEX $535,666,000.00
  • Revenue This Year
  • PRTA N/A
  • IBEX $9.12
  • Revenue Next Year
  • PRTA $389.77
  • IBEX $5.80
  • P/E Ratio
  • PRTA N/A
  • IBEX $13.11
  • Revenue Growth
  • PRTA N/A
  • IBEX 5.35
  • 52 Week Low
  • PRTA $4.32
  • IBEX $16.35
  • 52 Week High
  • PRTA $22.83
  • IBEX $32.08
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.73
  • IBEX 53.17
  • Support Level
  • PRTA $8.05
  • IBEX $28.99
  • Resistance Level
  • PRTA $8.73
  • IBEX $30.34
  • Average True Range (ATR)
  • PRTA 0.38
  • IBEX 0.75
  • MACD
  • PRTA -0.05
  • IBEX 0.08
  • Stochastic Oscillator
  • PRTA 47.62
  • IBEX 61.06

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: